Public-Private Interface News

Steve Greenspon '09, CEO of Honey-Can-Do International, speaks with fellow panelists during the Entrepreneurship as Your Next Career session on November 16, 2016. The session focused on the specific challenges and opportunities that arise when starting a business.

Growth 2016

Leaders Tell Kellogg Students: Growth Only Limited by Imagination

Full Story

Tennessee Hints at Chaos If Republicans Leave Obamacare in Limbo

02/16/17 – Bloomberg
Article explains how at least 40,000 people in the Knoxville area may have no health plans to pick from in the ACA’s markets after insurer Humana Inc. opted to pull out from all 11 states where it still sell plans in 2018, quoting Professor Craig Garthwaite on how if insurers make the decision that the markets aren’t a good business opportunity, that’ll undermine the system.

Trump boycotts leave companies caught in the crossfire

02/03/17 – CBC News
Despite the fact that the new administration has only been in power for nearly two weeks, there has been no shortage of controversy. Consumers have been active in boycotting companies, policies, and using the power of their wallet to show their reluctance to comply the new administration's policies. Brayden King, Chair at the Kellogg School of Management, spoke about the recent controversy regarding Uber and the new administration. "It created an opportunity for activists to make some noise," King said. "Uber was the opportunity, not the target itself."

Contest For Biz Students Is All About Umbilical Cords

02/02/17 – NPR
Article explains that at the Kellogg Biotech and Healthcare Competition, MBA students came up with plans to get moms and dads to use an antiseptic on the cord stump to ward off infection, quoting Professor Tim Calkins on the ideas and solutions generated from the competition.

Success and Failure in the Insurance Exchanges

02/01/17 – The New England Journal of Medicine
The article about the future of the Affordable Care Act (ACA) under the Trump administration is co-authored by Professor Craig Garthwaite.

Trump Spoils Pharma Chiefs With No More Bad News on Drug Pricing

01/31/17 – Bloomberg
Article discusses Trump’s recent meeting with various heads of pharmaceutical companies, insisting that the drug makers shift manufacturing to the U.S., and quotes Professor Craig Garthwaite on how moving factories to the U.S. is not going to save money.

Beware Of False Claims That Obamacare Repeal Will Kill Thousands Of Americans

01/30/17 – Forbes
Article cites research by Professor David Dranove, which says that if a regression model does not include all possible factors that might predict mortality, and just one of these omitted factors is correlated with insurance status, then the reported coefficient on insurance status is biased.

This Kellogg MBA Is Revolutionizing K-8 Education

01/27/17 – Poets & Quants
Article features Kellogg alum Sidharth Kakkar’s education start-up, Front Row Education, which is revolutionizing K-8 education with online programming and has seen remarkable growth in the two years since its launch.

It’s the Drug Industry’s Turn to Tremble Before Trump

01/12/17 – Bloomberg
Article explains how U.S. taxpayers and patients essentially subsidize the drug industry, yet there is a huge payoff for the system, quoting Professor Craig Garthwaite on how subsidies have also made the U.S. a cradle of biopharmaceutical innovation. “As a country, I don’t think we’re really there yet that we want some of these innovations to not be available to people.”

The Trump Era Corporate Boycott

01/09/17 – The New Yorker
This article discusses the new challenges companies face today in the Trump political climate. Numerous companies including Pepsi and New Balance have fallen victim to boycotts due to comments that have made about Trump and politics. The article noted that company boycotts have occurred throughout history, however, the boycotts taking place now because of Trump comments are not driven by things relevant to the companies' business practices. The article highlights the work of Professor Brayden King who studied high-profile boycotts between 1990 and 2005 and found that, amongst other findings, "a company's stock price fell, on average, every day that the boycott was in the news."

In Age Of Trump, B-Schools Brace For Upheaval

12/29/16 – Poets and Quants
Professor Craig Garthwaite is featured in Poets & Quants on the November election's impact on the ACA landscape.

Our Favorite MBA Startups Of 2016

12/29/16 – Poets & Quants
Article discusses the publication’s favorite ventures from 2016, highlighting Kellogg alum Andrew Youn’s One Acre Fund, a nonprofit that loans money to small rural farmers, and trains them in farming techniques.

United Way Searches for Its Place in a World of One-Click Giving

12/23/16 – The New York Times
Article discusses how United Way chapters are left scrambling to prove they are addressing the causes that matter most to people in their communities, quoting Professor Megan Kashner on the “identified victim effect,” which posits that many donors prefer to help individuals who are not anonymous.

The 12 best opinion pieces of 2016

12/22/16 – Crain’s Chicago Business
Professor Craig Garthwaite’s article on EpiPen drug pricing was named one of the top 12 opinion articles published in Crain’s in 2016.

Rigging Charge Exposes One Reason for Inexplicable Drug Pricing

12/16/16 – Bloomberg
Article explores the topic of drug pricing, noting that inexplicable pricing is widespread in the U.S. market for generic antibiotics. Since 2012, list prices for tetracycline, which treats pneumonia and urinary tract infections, have soared to 170 times the old price. “It’s a market failure,” says Professor Craig Garthwaite.

The Growing Demand For Social Impact Education

12/12/16 – Poets & Quants: We See Genius
Article by Professor Liz Livingston Howard discusses how universities are rising to the call of more social enterprise education.

From Chocolate to Coffee: Addressing Poverty Along the Supply Chain​

11/30/16 – Huffington Post
Article written by Professor Megan Kashner discusses how to address poverty along the supply with tools such as the Progress out of Poverty Index, a statistically-normed tool used by organizations and businesses to track the economic progress out of poverty by individuals and families in a particular community or supply chain network.

Anthem-Cigna Deal Seen by U.S. Economist as Risk to Competition

11/28/16 – Bloomberg
Article quotes Professor David Dranove, who served as a witness in the U.S. government’s lawsuit to block the proposed Anthem-Cigna $48 billion merger. “The merger will harm competition in the market for national accounts” as well as in states where Anthem operates, he said. Coverage also appeared in Politico, Insurance Journal, Law360 and Healthcare Dive.

A new Vox podcast about how policy affects real people

11/21/16 – Vox
Professor Craig Garthwaite discusses the threshold for drug price versus innovation--how comfortable should Americans be paying higher prices for drugs to get more innovation? What is more important: continued drug innovation or more accessible drugs?

Richards-Kortum, Oden, Palamountain: All babies deserve a chance to survive

11/18/16 – Houston Chronicle
Op-ed co-authored by Research Associate Professor Kara Palamountain '04 illustrating the link between infant survival rates and economic development in poorer nations.

New Kellogg courses address emerging global business issues, expand dynamic programming

11/10/16 – 11 new courses emerge from Kellogg’s cross-disciplinary strategic initiatives and academic departments

Full Story
Prev 20